Guru Ownership Trend
Guru Analysis for Xeris Biopharma Holdings, Inc. (XERS)
Xeris Biopharma Holdings, Inc. (XERS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $21.93 M.
Top institutional holders include Cliff Asness and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $1.33 M net inflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 234.5%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 85.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Xeris Biopharma Holdings, Inc. (XERS)
Major holders include Cliff Asness ($12.2 M), Chuck Royce ($3.65 M), Jefferies Group ($2.33 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.51 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.33 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited XERS. The total reported sell value was $3.73 M.
Yes, 0 managers opened new positions in XERS, and 4 increased their existing holdings. The total reported buy value was $5.05 M.